Cost Effectiveness of Increasing the Dose Intensity of Chemotherapy with Granulocyte Colony-Stimulating Factor in Small-Cell Lung Cancer: Based on Data from the Medical Research Council LU19 Trial
Year of publication: |
2006
|
---|---|
Authors: | Bojke, Laura ; Sculpher, Mark ; Stephens, Richard ; Qian, Wendi ; Thatcher, Nick ; Girling, David |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 24.2006, 5, p. 443-452
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Cost-effectiveness | Cost-utility | Cyclophosphamide | Doxorubicin | Etoposide | Lenograstim | Neutropenia | Small-cell-lung-cancer |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Marino, Patricia, (2003)
-
Calhoun, Elizabeth A., (2005)
-
Pharmacoeconomics of the Myeloid Growth Factors: A Critical and Systematic Review
Hirsch, Bradford R., (2012)
- More ...
-
Bojke, Laura, (2008)
-
Longworth, Louise, (2009)
-
Bojke, Laura, (2007)
- More ...